Atlas Trials

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Clinical trial NCT00006010 · COMPLETED

Trial details

NCT number
NCT00006010
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2001-09-01
Primary completion
2004-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.